Hide

FocusBar

Subscribe to Premium Member
Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M63,020Revenue $M22,603Net Margin (%)18.1Z-Score4.4
Enterprise Value $M62,867EPS $4.2Operating Margin %23.9F-Score6
P/E(ttm))13.4Cash Flow Per Share $5.4Pre-tax Margin (%)23.9Higher ROA y-yY
Price/Book4.310-y EBITDA Growth Rate %7.0Quick Ratio1.3Cash flow > EarningsY
Price/Sales2.85-y EBITDA Growth Rate %29.8Current Ratio2.0Lower Leverage y-yY
Price/Cash Flow9.1y-y EBITDA Growth Rate %-2.5ROA % (ttm)11.9Higher Current Ratio y-yN
Dividend Yield %3.5Insider Buy (3m)0ROE % (ttm)27.7Less Shares Outstanding y-yN
Payout Ratio %60.0Shares Outstanding M1,134ROI % (ttm)18.9Gross Margin Increase y-yY

Gurus Latest Trades with LLY

Please Subscribe to see portfolio changes after the end of the last quarter. Real Time Picks are included for Premium Members only! Plans start from as little as $299/year.

7-Day FREE TRIAL
Number of guru portfolios checked: 80. The trades of Premium Gurus are not included unless they are in your Personalized List

TickerdownGuruDate Action
Impact Price Range
(Average)*
Current Price Change from Average Comment Current Shares
LLYJoel Greenblatt 2012-06-30 Reduce-0.13%$39.49 - $42.66
($40.92)
$ 55.937%Reduce -53.72%33,227
LLYDavid Dreman 2012-06-30 Sold Out -0.02%$39.49 - $42.66
($40.92)
$ 55.937%Sold Out0
LLYHOTCHKIS & WILEY 2012-03-31 Reduce-0.43%$38.49 - $41.8
($37.26)
$ 55.950%Reduce -35.54%2,916,880
LLYJoel Greenblatt 2012-03-31 Add0.08%$38.49 - $41.8
($37.26)
$ 55.950%Add 44.74%71,802
LLYJohn Hussman 2012-03-31 Add0.8%$38.49 - $41.8
($37.26)
$ 55.950%Add 80.08%2,251,000
LLYKen Fisher 2012-03-31 Sold Out -0.01%$38.49 - $41.8
($37.26)
$ 55.950%Sold Out0
LLYVanguard Health Care Fund 2011-12-31 Reduce-0.17%$35.58 - $41.75
($38.33)
$ 55.946%Reduce -5.06%15,964,300
LLYJohn Hussman 2011-12-31 Add0.33%$35.58 - $41.75
($38.33)
$ 55.946%Add 66.67%1,250,000
LLYJean-Marie Eveillard 2011-12-31 Sold Out -0.0014%$35.58 - $41.75
($38.33)
$ 55.946%Sold Out0
LLYRay Dalio 2011-12-31 Sold Out -0.11%$35.58 - $41.75
($38.33)
$ 55.946%Sold Out0
LLYCharles Brandes 2011-12-31 Reduce-0.51%$35.58 - $41.75
($38.33)
$ 55.946%Reduce -25.78%4,252,033
LLYChris Davis 2011-12-31 Buy 0.03%$35.58 - $41.75
($38.33)
$ 55.946%New holding, 337533 sh.337,533
LLYDavid Dreman 2011-12-31 Reduce-0.01%$35.58 - $41.75
($38.33)
$ 55.946%Reduce -27.68%22,876
LLYRay Dalio 2011-09-30 Reduce-0.06%$34.49 - $39.32
($36.93)
$ 55.951%Reduce -34.82%201,060
LLYHOTCHKIS & WILEY 2011-09-30 Reduce-0.53%$34.49 - $39.32
($37.04)
$ 55.951%Reduce -30.71%5,469,938
LLYJoel Greenblatt 2011-09-30 Add0.05%$34.49 - $39.32
($37.04)
$ 55.951%Add 27.03%42,705
LLYBruce Berkowitz 2011-09-30 Sold Out -0.0607%$34.49 - $39.32
($37.04)
$ 55.951%Sold Out0
LLYBrian Rogers 2011-09-30 Sold Out -0.4616%$34.49 - $39.32
($37.04)
$ 55.951%Sold Out0
LLYJohn Hussman 2011-06-30 Buy 0.45%$34.99 - $39.15
($37.29)
$ 55.950%New holding, 750000 sh.750,000
LLYJoel Greenblatt 2011-06-30 Add0.05%$34.99 - $39.15
($37.29)
$ 55.950%Add 40.9%33,619
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

LLY is held by these Gurus:

Ticker Guru Name Portfolio Date* Current Shares % of Shares Outstanding % of Total Assets Managed Change from Last Holdings Holding History
LLY Joel Greenblatt 2013-03-313,96100.01New Buy
LLY Ken Fisher 2013-03-313,90000New Buy
LLY Vanguard Health Care Fund 2013-03-3115,364,3001.353.4
LLY Dodge & Cox 2013-03-3136,06000
LLY Chris Davis 2013-03-31283,7090.030.04-2.73%
LLY PRIMECAP Management 2013-03-3146,844,8764.133.9-3.65%
LLY Charles Brandes 2013-03-312,037,0640.181.4-9.02%
LLY Mario Gabelli 2013-03-31142,5000.010.05-13.48%
LLY George Soros 2013-03-3155,00000.04-45%
LLY John Hussman 2013-03-31601,0000.051.3-57.1%
LLY HOTCHKIS & WILEY 2013-03-31407,6500.040.12-73.82%
LLY Ray Dalio 2013-03-31000Sold Out
Premium Most recent portfolio changes are included for Premium Members only!


LLY: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Conterno Enrique ASr. VP & Pres., Lilly Diabetes 2013-05-15Sell5,000$56.15-0.45view
Simmons Jeffrey NSVP&Pres.,Elanco Animal Health 2013-05-10Sell10,000$54.492.59view
Mahony SusanSVP & Pres., Lilly Oncology 2013-04-29Sell3,500$56.33-0.76view
Conterno Enrique ASr. VP & Pres., Lilly Diabetes 2013-04-15Sell5,000$57.1-2.1view
Mahony SusanSVP & Pres., Lilly Oncology 2013-03-26Sell5,000$56-0.18view
Lundberg Jan MEVP,Science&Tech and Pres. LRL 2013-03-12Sell19,000$55.380.94view
Ricks David ASVP and Pres, Lilly Bio-Meds 2013-02-08Sell3,000$53.913.69view
Rice Derica WEVP-Global Services and CFO 2013-02-05Sell29,646$54.213.12view
Mahony SusanSVP & Pres., Lilly Oncology 2013-02-01Sell5,000$54.282.98view
Tapiero JacquesSVP&Pres., Emerging Markets 2013-01-30Sell15,000$54.143.25view

Press Releases about LLY:

Quarterly/Annual Reports about LLY:

News about LLY:

Articles On GuruFocus.com
20 Best-Yielding Health Care Stocks - Less Volatile Than the Market Apr 02 2013 
Abbvie Inc. (ABBV) Dividend Stock Analysis Mar 22 2013 
52-Week High Mar 11 2013 
10 Best Dividend Paying Drug Manufacturing Stocks Mar 02 2013 
Abbott Laboratories (ABT) Dividend Stock Analysis Dec 27 2012 
Becton, Dickinson and Co. (BDX) Dividend Stock Analysis Nov 23 2012 
Johnson & Johnson (JNJ) Dividend Stock Analysis Nov 15 2012 
Any More Upside in Eli Lilly? Oct 10 2012 
Guru Stocks at 52-Week High: CMCSA, LLY, DGX, IP, ROP Oct 08 2012 
Lilly Looms Over Patent Precipice Sep 30 2012 

More From Our Partners
U.S. Steel, Genomic Health and Other Stocks Insiders Are Buying May 18 2013 - BENZINGA

Add Notes, Comments or Ask Questions

Comments

No comment yet
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names
Free 7-day Trial